Serveur d'exploration Lota lota - Analysis (UK)

Index « Auteurs » - entrée « Athol U. Wells »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Athanasios Megaritis < Athol U. Wells < B N Shah  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000006 (2013) Harpreet K. Lota [Royaume-Uni] ; Athol U. WellsThe evolving pharmacotherapy of pulmonary fibrosis.
000010 (2013) Harpreet K. Lota [Royaume-Uni] ; Gregory J. Keir [Royaume-Uni] ; David M. Hansell [Royaume-Uni] ; Andrew G. Nicholson [Royaume-Uni] ; Toby M. Maher [Royaume-Uni] ; Athol U. Wells [Royaume-Uni] ; Elisabetta A. Renzoni [Royaume-Uni]Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment
000012 (2013) Harpreet K. Lota [Royaume-Uni] ; Michael Dusmet [Royaume-Uni] ; Katrine Steele [Royaume-Uni] ; Athol U. Wells [Royaume-Uni] ; Andrew G. Nicholson [Royaume-Uni] ; David M. Hansell [Royaume-Uni] ; Elisabetta A. Renzoni [Royaume-Uni]A rapidly growing lung mass with air crescent formation

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Humans (MeSH)
2Disease Progression (MeSH)
2Lung (pathology)
2Middle Aged (MeSH)
2Tomography, X-Ray Computed (MeSH)
1Acetylcysteine (therapeutic use)
1Alveolitis, Extrinsic Allergic (diagnosis)
1Alveolitis, Extrinsic Allergic (drug therapy)
1Alveolitis, Extrinsic Allergic (physiopathology)
1Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
1Antibodies, Monoclonal, Murine-Derived (MeSH)
1Antibodies, Monoclonal, Murine-Derived (therapeutic use)
1Antigens, CD20 (MeSH)
1Antineoplastic Combined Chemotherapy Protocols (MeSH)
1Biopsy (MeSH)
1Cyclophosphamide (MeSH)
1Doxorubicin (MeSH)
1Female (MeSH)
1Follow-Up Studies (MeSH)
1Idiopathic Interstitial Pneumonias (complications)
1Idiopathic Interstitial Pneumonias (drug therapy)
1Immunocompromised Host (MeSH)
1Immunologic Factors (therapeutic use)
1Immunosuppressive Agents (therapeutic use)
1Indoles (therapeutic use)
1Lung (physiopathology)
1Lung Diseases, Interstitial (complications)
1Lung Diseases, Interstitial (drug therapy)
1Lung Neoplasms (diagnosis)
1Lung Neoplasms (pathology)
1Lymphoma, Large B-Cell, Diffuse (drug therapy)
1Lymphomatoid Granulomatosis (diagnosis)
1Lymphomatoid Granulomatosis (drug therapy)
1Lymphomatoid Granulomatosis (pathology)
1Male (MeSH)
1Prednisone (MeSH)
1Pulmonary Fibrosis (drug therapy)
1Pulmonary Fibrosis (etiology)
1Pyridones (therapeutic use)
1Randomized Controlled Trials as Topic (MeSH)
1Rituximab (MeSH)
1Sarcoidosis, Pulmonary (complications)
1Sarcoidosis, Pulmonary (drug therapy)
1Scleroderma, Systemic (complications)
1Scleroderma, Systemic (drug therapy)
1Treatment Outcome (MeSH)
1Vincristine (MeSH)
1Vital Capacity (MeSH)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Eau/explor/LotaV3/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Athol U. Wells" 
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Athol U. Wells" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Eau
   |area=    LotaV3
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Athol U. Wells
}}

Wicri

This area was generated with Dilib version V0.6.39.
Data generation: Fri May 20 09:58:26 2022. Site generation: Fri May 20 10:24:07 2022